SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019260
Filing Date
2016-05-12
Accepted
2016-05-12 16:59:33
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cdtx-10q_20160331.htm 10-Q 1048856
2 EX-31.1 cdtx-ex311_9.htm EX-31.1 9353
3 EX-31.2 cdtx-ex312_10.htm EX-31.2 9600
4 EX-32.1 cdtx-ex321_7.htm EX-32.1 6425
5 EX-32.2 cdtx-ex322_8.htm EX-32.2 6285
  Complete submission text file 0001564590-16-019260.txt   3567380

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20160331.xml EX-101.INS 691718
7 XBRL TAXONOMY EXTENSION SCHEMA cdtx-20160331.xsd EX-101.SCH 25457
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdtx-20160331_cal.xml EX-101.CAL 26010
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdtx-20160331_def.xml EX-101.DEF 89731
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdtx-20160331_lab.xml EX-101.LAB 221815
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdtx-20160331_pre.xml EX-101.PRE 166759
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 161644757
SIC: 2836 Biological Products, (No Diagnostic Substances)